Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissue

Journal of Clinical Biochemistry and Nutrition

Volumn 52, Issue 2, 2013, Pages 112-119

  Song, Junmin ^a,c   Futagami, Seiji ^a   Nagoya, Hiroyuki ^a   Kawagoe, Tetsuro ^a   Yamawaki, Hiroshi ^a   Kodaka, Yasuhiro ^a   Tatsuguchi, Atsushi ^a   Gudis, Katya ^a   Wakabayashi, Taiga ^a   Yonezawa, Masaoki ^a   Shimpuku, Mayumi ^a   Watarai, Yasuhiko ^d   Iwakiri, Katsuhiko ^a   Hoshihara, Yoshio ^e   Makino, Hiroshi ^b   Miyashita, Masao ^b   Tsuchiya, Shinichi ^d   Li, Yan ^c   Crowe, Sheila E ^f   Sakamoto, Choitsu ^a  

^a Department of Medicine   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

^d NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^e Ministry of International Trade and Industry   (Japan)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

APE 1; Esophageal squamous cell carcinoma; MCP 1; NF B p65; P65 NLS

Indexed keywords

APURINIC APYRIMIDINIC ENDONUCLEASE 1; ENDONUCLEASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 84875906015     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-95     Document Type: Article

References (32)

1. Xiao ZF, Yang ZY, Liang J, et al. Value of radiotlierapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003; 75:331-336. (Pubitemid 36184465)
2. Shimizu K, Hihara J, Yoshida K, Toge T. Clinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus. Hiroshima J Med Sci 2005; 54: 67-71. (Pubitemid 41355099)
3. Hagymási K, Tulassay Z. Risk factors for esophageal cancer, and possible genetic background. Orv Hetil 2009; 150: 407-413.
4. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009; 24: 729-735.
5. Meredith KL, Weber JM, Turaga KK, et al. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol 2010; 17: 1159-1167.
6. Loeb LA, Preston BD. Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 1986; 20:201-230.
7. Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APEl) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APEl expression inhibition. Mol Cancer Ther 2004; 3: 679-686. (Pubitemid 39193748)
8. Koukourakis MI, Giatromanolaki A, Kakolyris S, et al. Nuclear expression of human apurinic/apyrimidinic endonuclease (HAPI/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. Int J Radial Oncol Biol Phys 2001; 50: 27-36.
9. Wang D, Xiang DB, Yang XQ, et al. APEl overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APEl enhances the activity of cisplatin in A549 cells. Lung Cancer 2009; 66; 298-304.
10. Futagami S, Hiratsuka T, Shindo T, et al. Expression of apurinic/apyrimidinic endonuclease-1 (APE-1) in H. pylori-associated gastritis, gastric adenoma, and gastric cancer. Helicobacter 2008; 13: 209-218. (Pubitemid 351667076)
11. Di Maso V, Avellini C, Crocè LS, et al. Subcellular localization of APEI/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med 2007; 13: 89-96. (Pubitemid 46786837)
12. Jiang Y, Zhou S, Sandusky GE, Kelley MR, Fishel ML. Reduced expression of DNA repair and redox signaling protein APEI/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression. Cancer Invest 2010; 28: 885-895.
13. Obtulowicz T, Swoboda M, Speina E, et al. Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients. Mutagenesis 2010; 25: 463-471.
14. Taimer B, Grimme S, Schiffer I, et al. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas. Gynecol Oncol 2004; 92: 568-577. (Pubitemid 38183146)
15. Luo M, Kelley MR. Inhibition of the human apurinic/apyrimidinic endonuclease (APEl) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res 2004; 24: 2127-2134. (Pubitemid 39166286)
16. Li B, Li YY, Tsao SW, Cheung AL. Targeting NF-κB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer. Mol Cancer Ther 2009; 8: 2635-2644.
17. Tian F, Zang WD, Hou WH, Liu HT, Xue LX. Nuclear factor-κb signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin (Shanghai) 2006; 38: 318-326.
18. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem Pharmacol 2002; 64: 963-970. (Pubitemid 35232270)
19. Jenkins GJ, Mikhail J, Alhamdani A, et al. Immunohistochemical study of nuclear factor-kb activity and interieukin-8 abundance in oesophageal adenocarcinoma; a usefiil strategy for monitoring these biomarkers. J Clin Pathol 2001; 60: 1232-1237.
20. Viedt C, Dechend R, Fei J, Hänsch GM, Kreuzer J, Orth SR. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kb and activating protein-1. J Am Sac Nephrol 2002; 13: 1534-1547. (Pubitemid 34579243)
21. Charalambous MP, Lightfoot T, Speirs V, Horgan K, Gooderham NJ. Expression of COX-2, NF-κb-p65, NF-κb-p50 and IKKα in malignant and adjacent normal human colorectal tissue. Br. J Cancer 2009; 101: 106-115.
22. Ohta M, Kitadai Y, Tanaka S, et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002; 102: 220-224. (Pubitemid 35222287)
23. Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastroinlest Liver Physiol 2010; 298: G571-G581.
24. Abdel-Latif MM, Duggan S, Reynolds JV, Keller D. Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 2009; 9: 396-404.
25. Kakolyris S, Kaklamanis L, Engels K, et al. Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence. Cancer Res 1997; 57: 1794-1797. (Pubitemid 27199675)
26. Wu HH, Cheng YW, Chang JT, et al. Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-κB activation. Oncogene 2010; 29: 4330-4340.
27. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APEI/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009; 11: 601-620.
28. Kelley MR, Parsons SH. Redox regulation of the DNA repair function of the human AP endonuclease Apel/ref-l. Antioxid Redox Signal 2001; 3: 671-683. (Pubitemid 32785989)
29. Ando K, Hirao S, Kabe Y, et al. A new APEI/Ref-1-dependent pathway leading to reduction of NF-κB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 2008; 36: 4327-4336.
30. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)ldU-induced DNA double-strand breaks with γ-H2AX antibody. Radial Res 2002; 158: 486-492.
31. Wang S, Xu M, Li F, et al. Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1. Breast Cancer Res Treat 2012; 133: 1037-1048.
32. Lazar M, Sullivan J, Chipitsyna G, et al. Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin. Surgery 2010; 148: 298-309.